Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 1.02B | $ 1.22B | $ 1.20B | $ 1.26B | $ 1.20B |
Total Assets | $ 3.73B | $ 3.70B | $ 3.58B | $ 3.50B | $ 3.62B |
Total Debt | $ 1.51B | $ 1.40B | $ 1.42B | $ 1.36B | $ 1.75B |
Net Debt | $ 496.00M | $ 179.00M | $ 224.70M | $ 101.00M | $ 549.90M |
Total Liabilities | $ 2.20B | $ 2.08B | $ 2.04B | $ 1.94B | $ 2.35B |
Stockholders Equity | $ 1.52B | $ 1.61B | $ 1.53B | $ 1.56B | $ 1.27B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |